These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7916651)

  • 21. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
    Bellahcène A; Antoine N; Clausse N; Tagliabue E; Fisher LW; Kerr JM; Jarès P; Castronovo V
    Lab Invest; 1996 Aug; 75(2):203-10. PubMed ID: 8765320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor mutations in tamoxifen-resistant breast cancer.
    Karnik PS; Kulkarni S; Liu XP; Budd GT; Bukowski RM
    Cancer Res; 1994 Jan; 54(2):349-53. PubMed ID: 8275466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
    Zhang QX; Borg A; Fuqua SA
    Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
    Fasco MJ
    Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta.
    Inoue S; Ogawa S; Horie K; Hoshino S; Goto W; Hosoi T; Tsutsumi O; Muramatsu M; Ouchi Y
    Biochem Biophys Res Commun; 2000 Dec; 279(3):814-9. PubMed ID: 11162434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases.
    Leygue E; Hall RE; Dotzlaw H; Watson PH; Murphy LC
    Br J Cancer; 1999 Feb; 79(5-6):978-83. PubMed ID: 10070900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
    Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
    Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
    Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
    Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
    J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.
    Reinholz MM; Zschunke MA; Roche PC
    Gynecol Oncol; 2000 Nov; 79(2):264-71. PubMed ID: 11063655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue.
    Bièche I; Lidereau R
    Cancer Res; 1999 Jun; 59(11):2546-50. PubMed ID: 10363970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer.
    Decouvelaere C; Peyrat JP; Bonneterre J; Djiane J; Jammes H
    Cell Growth Differ; 1995 Apr; 6(4):477-83. PubMed ID: 7794815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning of estrogen-responsive messenger RNAs in the T-47D human breast cancer cell line.
    Manning DL; Archibald LH; Ow KT
    Cancer Res; 1990 Jul; 50(13):4098-104. PubMed ID: 2354459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells.
    May FE; Westley BR
    Cancer Res; 1986 Dec; 46(12 Pt 1):6034-40. PubMed ID: 2430688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma.
    Villa E; Camellini L; Dugani A; Zucchi F; Grottola A; Merighi A; Buttafoco P; Losi L; Manenti F
    Cancer Res; 1995 Feb; 55(3):498-500. PubMed ID: 7834616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells.
    Miksicek RJ; Lei Y; Wang Y
    Breast Cancer Res Treat; 1993; 26(2):163-74. PubMed ID: 8219253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of estrogen receptor variant mRNAs from human breast cancers.
    Dotzlaw H; Alkhalaf M; Murphy LC
    Mol Endocrinol; 1992 May; 6(5):773-85. PubMed ID: 1603086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
    Poola I; Speirs V
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mutations in the estrogen receptor messenger RNA in human breast cancers.
    Murphy LC; Wang M; Coutt A; Dotzlaw H
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1420-7. PubMed ID: 8636345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.